levocetirizine dihydrochloride

ApprovedSmall molecule

levocetirizine dihydrochloride is one of 141 small molecule programs targeting Allergic Rhinitis. It is currently in Approved.

Indications

Total Trials

Active Trials

140

Competitors

Pipeline

Status by Indication[3][1]

Indication

Allergic RhinitisApproved

Allergic AsthmaCompleted

Atopic DermatitisActive, not recruiting

AsthmaActive, not recruiting

Seasonal Allergic RhinitisActive, not recruiting

Chronic Idiopathic UrticariaActive, not recruiting

Allergic RhinitisApproved

Approved

Allergic AsthmaPhase 3

Completed

Atopic DermatitisApproved

Active, not recruiting

AsthmaPhase 3

Active, not recruiting

Seasonal Allergic RhinitisApproved

Active, not recruiting

Chronic Idiopathic UrticariaPhase 3

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

levocetirizine dihydrochloride

UCB

Approved

14 2

Singulair

AstraZeneca

Preclinical

17 3

Atrovent

Boehringer Ingelheim

Preclinical

5 4

Symbicort

AstraZeneca

Preclinical

6 5

Decadron

QQuince Therapeutics S.p.A.

Preclinical

1 6

Tylenol

KKenvue Brands

Preclinical

1 7

Blood Withdrawn

Emergent BioSolutions

Preclinical

1 8

DUPIXENT

Regeneron

Preclinical

1 9

Aclidinium Bromide

Spiriva

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Seasonal Allergic Rhinitis5 trials

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

Completed· UCB logo

UCB·Phase 4·NCT00542607·94 enrolled

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Completed· UCB logo

UCB·Phase 4·NCT00621959·596 enrolled

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Completed· UCB logo

UCB·Phase 3·NCT00525278·67 enrolled

Show 2 more trials

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

Completed· UCB logo

UCB·Phase 4·NCT00653224·580 enrolled

Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects

Completed· UCB logo

UCB·Phase 3·NCT00544388·570 enrolled

Efficacy and Safety2 trials

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Completed· UCB logo

UCB·Phase 2·NCT00520754·15 enrolled

Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

Completed· UCB logo

UCB·N/A·NCT00521040·459 enrolled

Allergic Rhinitis2 trials

Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Completed· UCB logo

UCB·Phase 3·NCT00524836·71 enrolled

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Completed· UCB logo

UCB·Phase 4·NCT00521131·453 enrolled

Atopic Dermatitis1 trial

Management of Pruritus With Xyzal in Atopic Dermatitis

Completed·DDerm Research, PLLC·Phase 4·NCT00884325·40 enrolled

Fed1 trial

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

Completed·IIPCA Laboratories Ltd.·Phase 1·NCT01567501·28 enrolled

3 more indications

Chronic Idiopathic Urticaria1 trial

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

Completed· UCB logo

UCB·Phase 3·NCT00525382·134 enrolled

Allergic Asthma1 trial

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma

Completed·BBridgette Jones·Phase 3·NCT04699604·55 enrolled

Unspecified1 trial

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition

Completed·IIPCA Laboratories Ltd.·Phase 1·NCT01557439·28 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for levocetirizine dihydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — levocetirizine dihydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for levocetirizine dihydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — UCB company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UCB

levocetirizine dihydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Seasonal Allergic Rhinitis5 trials

Efficacy and Safety2 trials

Allergic Rhinitis2 trials

Atopic Dermatitis1 trial

Fed1 trial

Chronic Idiopathic Urticaria1 trial

Allergic Asthma1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News